FDA Clears Magstim Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
18 janv. 2023 13h05 HE
|
Magstim EGI
MINNEAPOLIS, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA...
Zai Lab Appoints Michel Vounatsos To Its Board of Directors
09 janv. 2023 07h30 HE
|
Zai Lab Limited
SHANGHAI and CAMBRIDGE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that Michel Vounatsos has been appointed to its Board of Directors,...
Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer
05 janv. 2023 08h00 HE
|
Reset Pharmaceuticals Inc.
NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental...
9th Annual “N20” Neuroscience20 (Brain, Spine, and Mental Health) Summit to Shed Light On $16T+ Global Cost of Neuro-psychiatric Disorders
10 nov. 2022 21h43 HE
|
Society for Brain Mapping & Therapeutics
LOS ANGELES, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Launched nine years ago, Neuroscience20 (N20) educates global leaders and Group of Twenty (G20) leaders about the cost of neurological, spine, and...
Reset Pharmaceuticals announces appointment of neuroscience industry leader Lisa Deschamps to the Board of Directors
02 nov. 2022 08h00 HE
|
Reset Pharmaceuticals Inc.
NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and commercialization of novel...
SportGait Partners With the Carrick Institute, Incorporating Cutting-Edge Concussion Support and Recovery Technology
26 oct. 2022 14h00 HE
|
SportGait
WILMINGTON, N.C., Oct. 26, 2022 (GLOBE NEWSWIRE) -- SportGait, the brain wellness and medical technology company, proudly announced today a partnership with The Carrick Institute, world leader in...
Omniscient Neurotechnology Appoints Two New Members to Its Board of Directors
24 oct. 2022 08h30 HE
|
Omniscient Neurotechnology
SYDNEY, Australia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Omniscient Neurotechnology, the brain mapping company creating new possibilities in brain health, today announced the appointment of Barbara...
Human Augmentation Market Size Worth $498+ Billion, Globally, by 2028 at 23% CAGR - Exclusive Study by The Insight Partners
11 oct. 2022 09h17 HE
|
The Insight Partners
New York, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Human Augmentation Market Size and Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product Type (Wearable...
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
29 sept. 2022 07h28 HE
|
Axsome Therapeutics, Inc.
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Feel Therapeutics Launches its Ground-breaking Digital Precision Medicine Platform to Enable the Era of Precision Neuroscience and Psychiatry
22 sept. 2022 07h41 HE
|
Feel Therapeutics
SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Feel Therapeutics Inc., a leading company developing digital biomarkers and therapeutics to bring objective measurement and data in mental health,...